Molecular Partners AG Cash Flow Quality Index
Molecular Partners AG cash flow quality index. Molecular Partners AG (MOLN) has a Cash Flow Quality Index of 1.07x as of March 2022. Operating cash flow of CHF163.56 Million exceeds net income of CHF153.13 Million, indicating high earnings quality where cash backs reported profits. See MOLN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Molecular Partners AG (2013–2022)
Cash flow quality index of Molecular Partners AG from 2013 to 2022. Historical Cash Flow Quality Index for Molecular Partners AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore MOLN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Molecular Partners AG Cash Flow Quality Index by Year (2013–2022)
Molecular Partners AG cash flow quality index by year from 2013 to 2022. Year-by-year earnings quality comparison for Molecular Partners AG. For the full cash flow conversion analysis, see MOLN cash flow conversion.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.01x | CHF118.57 Million | CHF117.85 Million | ▲ +152.8% |
| 2013 | -1.91x | CHF-13.61 Million | CHF7.14 Million | — |